Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5-Reference-Cited by-同舟云学术

Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5

Published:2013-03 Issue:3 Volume:24 Page:245-258
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Maier Dawn A.¹,Brennan Andrea L.¹,Jiang Shuguang¹,Binder-Scholl Gwendolyn K.¹,Lee Gary²,Plesa Gabriela¹,Zheng Zhaohui¹,Cotte Julio¹,Carpenito Carmine¹,Wood Travis²,Spratt S. Kaye²,Ando Dale²,Gregory Philip²,Holmes Michael C.²,Perez Elena. E.¹,Riley James L.³,Carroll Richard G.¹,June Carl H.¹,Levine Bruce L.¹

Affiliation:

1. Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.

2. Sangamo BioSciences, Richmond, CA 94804.

3. Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2012.172

Reference78 articles.

1. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation